| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.9 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |